Stay updated on Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial

Sign up to get notified when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical-trial record for emapalumab and anakinra in patients with COVID-19 is displayed, including study design, eligibility, locations, and outcome measures. It also indicates that the study was terminated and is no longer recruiting.
    Difference
    67%
    Check dated 2026-11-07T13:22:14.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.8.0 instead of v3.7.2; the study record remains unavailable behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:18:25.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and FAQs about a terminology transition from “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-24T16:34:17.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T16:19:35.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T16:35:23.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    No changes were recorded for the page; the current view shows a 403 Forbidden error, indicating the study record is not accessible at this time.
    Difference
    0.2%
    Check dated 2026-09-26T18:35:47.000Z thumbnail image

Stay in the know with updates to Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.